Anti-PD-1 and anti-CTLA-4 antibodies could be used to increase the synergistic therapeutic efficiency for distant tumor suppression after treatment with the Au/Ag NRs and NIR-II laser irradiation. Here, PDCD1 is linked to neoplasm.